EDX Medical Group Plc (EDX) ORD GBP0.01

Sell:10.50pBuy:12.00p0.55p (5.12%)

Prices delayed by at least 15 minutes
Sell:10.50p
Buy:12.00p
Change:0.55p (5.12%)
Prices delayed by at least 15 minutes
Sell:10.50p
Buy:12.00p
Change:0.55p (5.12%)
Prices delayed by at least 15 minutes

Company Information

About this company

EDX Medical Group Plc is a United Kingdom-based company, which develops digital diagnostic products and services for the personalized treatment for cancer, heart disease and infectious diseases. The Company provides healthcare professionals and organizations with tools and services for predicting and managing diseases on a personalized basis. It provides tests for use by professionals or individuals at point-of-care, home, or workplace. Its products and services include Caris MI Profile, cResponse, Caris MI Tumor Seek Hybrid, Caris Assure, Testicular cancer testing, Prostate cancer super test, Bowel cancer super test, Multiple biomarker 5FU/ capecitabine pharmacogenomic drug safety and treatment management test, and Polymerase chain reaction (PCR) test, among others. The Caris MI Profile platform offers artificial intelligence (AI) solutions such as Caris GPsai and Caris FOLFIRSTai to guide clinicians in diagnosis and treatment of cancer patients.

Key people

Click to see more

Key facts

  • EPIC
    EDX
  • Location
    United Kingdom
  • Sector
    Healthcare
  • Industry
    Healthcare Facilities
  • ISIN
    GB00BNDMJS47
  • Market cap
    £40.02m
  • Employees
    21
  • Shares in issue
    372.06m
  • Exchange
    Aquis Stock Exchange
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.